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Background: The dietary composition associated to physical activity could play a significant role in improving
insulin sensitivity and reducing risk of diabetes and its complications. This study was designed to investigate
whether glycemic control, redox and inflammatory status impairments in patients with type 2 diabetes (T2D), were
improved after 90 (d90) and 180 (d180) days follow-up of nutritional advices.
Methods: Patients with T2D (n = 85) aged of 50 ± 8 years (Female/Male, 45/40), treated with oral antidiabetics
(OAD) alone, with a body mass index (BMI) of 26 ± 2, were recruited. At the beginning of the study (d0), patients
were instructed to follow-up nutritional advices adapted to T2D, and 30 to 45 min of walking per day. Assays were
realized at d90 and d180 of follow-up. Data were compared by student ‘t’ test and Pearson’s correlation coefficients
were determined between biochemical parameters and nutritional advices follow-up.
Results: Reduced glycated haemoglobin (HbA1c), glucose and total cholesterol (TC) were noted in patients with
T2D, at d90 and d180 compared to d0. Thiobarbituric acid reactive substances (TBARS) and hydroperoxyde levels
were lower at d90 and d180 than d0. Serum nitric oxide (NO) was decreased at d180 compared to d0 and d90. In
erythrocytes, superoxide dismutase (SOD) activity increased by 7% at d180 vs d0. Moreover, activity of glutathione
peroxidase (GPx) enhanced (P < 0.05), whereas that of glutathione reductase (GRed) decreased (P < 0.001) at d90 vs
d0. Resistin values were lower at d180 than d0 and d90 (P < 0.001). A progressive decrease in tumor necrosis
factor-α (TNF-α) was observed at d90 and d180 vs d0.
Conclusion: Nutritional advices associated to physical activity improve glycemic control, serum TC, redox and
inflammatory status in T2D, in particular after 3 months of counseling. However, these results need to be supported
with a longer dietary treatment and more rigorous control during the follow-up.
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Dietary and lifestyle approaches have a high potential for
the primary prevention of type 2 diabetes (T2D) [1].
This disease is a multistage process that begins as insulin
resistance (IR), characterized by body inability to use
properly its own insulin, and ends with exhaustion of
the insulin-producing pancreatic ß-cells, thereby leading
to hyperglycaemia [2]. Several factors are implicated in
T2D development, including obesity, family history,* Correspondence: bouchenak.malika@lncm-univoran.com
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unless otherwise stated.physical inactivity and inherited factors [2]. Moreover,
dietary composition could play a significant role in im-
proving insulin sensitivity and reducing risk of diabetes
and its complications [3]. Indeed, cardiovascular diseases
(CVD) are the major cause of morbidity and mortality in
T2D [4], knowing that cardiovascular risk is threefold
higher in T2D than in general population [5]. In Algeria,
the prevalence of T2D was about 10% in 2010 [6].
In T2D, the oxidative stress (OS) acts as a mediator of
IR, and its progression to glucose intolerance and instal-
lation of the pathology, possibly contributes to the rise
of several micro- and macro-vascular complications as-
sociated with diabetes [7]. In conditions of severe OS,l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Characteristics of patients with type 2 diabetes
T2D
Sex ratio (F/M) 45/40
Age (year) 50 ± 8
Weight (kg) 70 ± 9
BMI (kg/m2) 26 ± 2
Waist circumference (cm) 89 ± 8
Diabetes duration (year) 9 ± 3
Glycemia (g/L) 1.68 ± 0.65
HbA1c (%) 9.8 ± 1.9
Total cholesterol (mmol/L) 4.16 ± 0.70
Triglycerides (mmol/L) 1.15 ± 0.57
LDL-C (mmol/L) 1.20 ± 0.33
Data are mean ± SD of 85 patients. BMI: body mass index (weight (kg)/height
(m2)). HbA1c: glycated haemoglobin. LDL-C: low-density lipoproteins-cholesterol.
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function, which is due to low expression of antioxidant
enzymes [8].
However, clinical studies have also shown that specific
antioxidant concentrations in plasma and erythrocytes of
diabetes patients are reduced [9]. Indeed, superoxide dis-
mutase (SOD), glutathione peroxidase (GPx) and cata-
lase (CAT) activities scavenging reactive oxygen species
(ROS), were decreased in patients with T2D. Thus, the
improvement in oxidative stress status can contribute to
diabetes management [10].
Inflammation is considered to be a key regulator of
T2D pathogenesis, but the mechanism, by which it acts,
is still unknown. Tumor necrosis factor (TNF-α) is an
inflammatory cytokine implicated in metabolic disorders,
including obesity and IR. Several studies have shown
high levels of interleukin-6 (IL-6) and TNF-α among
individuals with clinically diagnosed diabetes [11]. More-
over, authors reported increased resistin levels in associ-
ation with obesity and IR in T2D [12], whereas other
study observed no change in resistin levels under such
conditions [13]. Data have shown that circulating resistin
levels were involved in promoting adiposity, but had no
effect on IR degree. These observations suggested that
the role of resistin in the pathogenesis of diabetes
remained controversial [14].
The purpose of the present study was to investigate
whether TD2 impaired glycemic control, redox and in-
flammatory status, and their improvement after 3 and
6 months follow-up of nutritional advices.
Methods
This study was conducted from November 2009 to June
2011 in the Hospital University Establishment (HUE)
(Internal Medicine) and polyclinics of Oran (west Algeria).
Patients with T2D since 9 ± 3 years (n = 85) (sex ratio
F/M, 45/40), with a mean age of 50 ± 8 years treated dur-
ing 8 ± 1 years with oral antidiabetics (OAD as biguanides
and/or sulfamides) only, with a body mass index (BMI)
(kg/m2) of 26 ± 2, fasting glycemia ≥ 7 mmol/L, triglyceri-
demia < 2 mmol/L, cholesterolemia < 5 mmol/L and low-
density lipoproteins-cholesterol (LDL-C) < 3.5 mmol/L.
Patients with other diabetes forms or T2D complicated
or treated with insulin, obesity, renal failure, hepatic and
thyroïd diseases, smoking, consuming of alcohols were
excluded. The clinical characteristics of patients are pre-
sented in Table 1.
This study was approved by the Institutional Ethic
Committee for Research on Human Subjects of the Uni-
versity of Oran. The protocol and the aim of the study
were explained to the patients and the investigation was
conducted with their written informed consent.
Nutritional counseling was designed to cover the nu-
tritional needs and maintain life quality of patients. Therecommended daily energy intake was 2000 Kilocalories
(Kcal) with 250 g of carbohydrates distributed over dif-
ferent meals in the day i.e. breakfast, morning snack,
lunch, afternoon snack and dinner. The advice given
promoted the consumption of fish meal, fruits and vege-
tables (FFV). Consumption of a dairy product at all the
three main meals daily, vegetables (2 times/d), fruits
(2–3 times/d), olive oil (2 table spoons/d), whole bread
daily at each meal, fish (2–3 times/week), with limited
eggs consumption (4–5 eggs/week) and moderate amounts
of red or white meats, sources of animal proteins, at lunch
and dinner were recommended. Moreover, patients were
instructed for 30 to 45 min of walking per day. The follow-
up was performed at d90 and d180.
Height and weight were performed using stadiometer
and balance (Weighting Scale ZT 220, China). Waist cir-
cumference (WC) was measured mid-way between the
lateral lower rib margin and the iliac crest (ombilicus).
Blood was drawn after a 12-hour overnight fasting by
antecubital venipuncture, at d0, d90 and d180, after life-
style advices. Serum and erythrocytes were collected by
low-speed centrifugation at 1000 g for 15 min. Serum
was preserved with 0.1% ethylene–diamine-tetraacetic
acid-disodium (Na2-EDTA). Erythrocytes were washed
two times with 0.9% sodium chloride (NaCl) solution,
and four times with cold water. Erythrocytes lysates were
preserved with 0.5% sodium dodecylsulfate (SDS, Sigma,
USA). Serum and erythrocytes lysates were stored at -70°C
until assays.
Serum glucose was measured by enzymatic colorimetric
test (kit Biocon, Germany). Serum insulin was determined
by an in vitro enzyme-linked immunosorbent assay
(ELISA) (kit Abcam, Cambridge, USA) for the quantitative
measurement of human serum insulin and proinsulin.
HbA1c was estimated by chromatographic spectophoto-
metric test (kit Biocon, Germany). Homeostatic model
Table 2 Clinical and biochemical parameters in TD2
patients after nutritional advices
d0 d90 d180
n = 85 n = 85 n = 35
Weight (kg) 70 ± 7 70 ± 9 69 ± 9
BMI (kg/m2) 26 ± 2 25 ± 2 24 ± 2
Waist circumference (cm) 89 ± 8 86 ± 7 88 ± 5
Hb1Ac (%) 9.8 ± 1.9 6.4 ± 1.7*** 8.4 ± 1.0§
Glucose (mmol/L) 7.71 ± 1.50 6.27 ± 1.56** 6.76 ± 0.77ǂ§
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serum insulin (μU/mL) × fasting plasma glucose (mmol/L)/
22.5) was determined [15].
Serum total cholesterol (TC), triglycerides (TG) and
uric acid (UA) levels were measured by enzymatic col-
orimetric tests (kits Biocon, Germany). Albumin was de-
termined by colorimetric method (Kit Biolabo, France).
Serum and erythrocytes lipid peroxidation was estimated
by measuring thiobarbituric acid reactive substances
(TBARS) [16]. The colored complex formed between mal-
ondialdehyde (MDA) and thiobarbituric acid (TBA) had
maximum absorbance at 532 nm. The serum hydroperox-
yde concentrations were determined by measuring cumin
hydroperoxyde (EqCuOOH) by comparison of the straight
line [17]. The absorbance was measured at 560 nm. Oxi-
dized proteins were estimated by measuring carbonyl con-
centrations, using the 2,4-dinitrophenylhydrazine [18]. The
absorbance was measured at 270 nm. Nitric oxide (NO)
determination was performed using Griess reagent (sulfa-
mide and n-naphtyl-ethylene diamine) [19]. Serum was
clarified by zinc sulfate solution and nitrate (NO3) was
then reduced to nitrite (NO2) by cadmium, overnight, at
20°C, under shaking. Serum was added to the Griess re-
agent and incubated for 20 min at 24°C. The absorbance
was measured at 540 nm.
SOD, GPx (EC 1.11.1.9) and GRed (EC 1.6.4.2) activ-
ities in erythrocytes were determined by kits (Sigma,
USA). SOD activity was assessed at 450 nm by measur-
ing the dismutation of superoxide radicals generated by
xantine oxidase and hypoxantine. The oxidation of
glutathione (GSH) to oxidized glutathione (GSSG) was
catalysed by GPx, which was then coupled to recycling
of GSSG back to GSH utilizing GRed and NADPH (re-
duced β-nicotinamide adenine dinucleotide phosphate)
(Sigma, USA). The activity was measured by the de-
crease in absorbance caused by the oxidation of NADPH
at 340 nm using an extinction coefficient (εmM) of 6.22
for NADPH. Catalase (CAT) (EC. 1.11.1.6) catalyses the
decomposition of hydrogen peroxide to water and oxy-
gen at 240 nm [20].
TNF-α was assayed by enzyme immunometric assay
(EIA) kit (Cayman Chemical’s ACE™ EIA kit, USA) per-
mitting TNF-α measurements within the range of
0–250 pg/ml. The lower limit of detection was 3.9 pg/
mL for TNF-α. The human resistin was determined by
EIA (SPI Bio – Bertin Pharma Branch kit, France). The
normal range was established for 8.1 ± 4.1 ng/ml.HOMA-IR 13.10 ± 4.32 12.53 ± 4.26 8.75 ± 1.20
Total cholesterol (mmol/L) 4.16 ± 0.70 3.47 ± 1.10** 3.09 ± 1.30§§
Triglycerides (mmol/L) 1.15 ± 0.57 0.73 ± 0.35** 1.26 ± 0.53ǂǂ
Values are means ± SD. d0, beginning of study; d90: 90 days and d180: 180 days
after initiating lifestyle advices. Data were analyzed using ‘t’ test. ***P < 0.001,
**P < 0.01 d90 vs d0; §§P < 0.01, §P < 0.05 d180 vs d0; ǂP < 0.05, ǂǂP < 0.01 d180
vs d90.Statistical analysis
The non-parametric student ‘t’ test (STATISTICA 5.0.)
was used to compare mean differences between d0, d90
and d180. Relationships between all the biochemical pa-
rameters and the nutritional advices follow-up weredetermined by the Pearson’s correlation coefficient.
P values <0.05 were considered significant.
Results
Among 85 patients with T2D, at d0 and after 3 months
of nutritional advices (d90), only 35 patients completed
this study at d180. The remaining patients became
hypertensive and/or were treated by insulin. There was
no significant difference in studied parameters when re-
lated to a gender.
There was no significant difference in body weight,
BMI and WC of T2D patients at d90 and d180 vs d0
(Table 2). HbA1c value decreased by 40% at d90 and by
20% at d180 compared to d0. A significant reduction in
glucose concentration at d90 vs d0 (19%) and d180 vs d0
(12%) was noted, whereas this value increased by 7% at
d180 vs d90. There was no significant difference in insu-
linemia and HOMA-IR, after lifestyle advices (Table 2).
Compared to d0, serum TC concentrations were low-
ered by 17% and 26% at d90 and d180, respectively.
Moreover, TG concentrations in patients with T2D were
reduced by 36% at d90 compared to d0, whereas, these
values increased by 42% at d180 compared to d90
(Table 2).
In serum, TBARS values were 1.34-fold lower at d90
and d180 than d0. Moreover, compared to d0, hydroper-
oxyde concentrations were l.6- and 2-fold lower at d90
and d180, respectively. There was no significant differ-
ence in carbonyl values after initiating lifestyle advices.
Serum NO was 1.4- and 1.2-fold lower at d180 than d0
and d90, respectively. UA values were 1.34-fold higher at
d180 than d0 (Table 3). Albumin concentration was sig-
nificantly enhanced at d90 vs d0 (P < 0.001).
In erythrocytes, SOD activity increased by 7% in T2D
at d180 vs d0. There was no significant change in CAT
activity of T2D patients during the follow-up, whereas,
Table 3 Redox status and inflammation markers in T2D patients after lifestyle advices
d0 d90 d180
n = 85 n = 85 n = 35
Serum
TBARS (μmol/ml) 6.53 ± 1.90 4.87 ± 1.31* 4.90 ± 1.77§
Hydroperoxydes (mmol/ml) 0.31 ± 0.06 0.19 ± 0.06*** 0.16 ± 0.06§§§
Carbonyls (nmol/mg prot) 1.07 ± 0.73 0.85 ± 0.41 0.80 ± 0,35
NO (mmol/ml) 2.26 ± 0.41 1.91 ± 0.36 1.57 ± 0.14§ǂ
Uric acid (μmol/L) 229.52 ± 67.10 238.10 ± 77.12 308.33 ± 118.52§
Albumin (g/L) 36.60 ± 12.50 51.00 ± 7.00*** 46.35 ± 5.43
Erythrocytes
SOD (U/gHb) 2430.11 ± 824.38 2045.37 ± 710.10 2622.00 ± 541.14ǂ
GPx (U/gHb) 3.14 ± 1.98 5.17 ± 2.63* 5.45 ± 3.08
GRed (U/gHb) 1.97 ± 0.61 1.15 ± 0.45** 1.52 ± 0,60
CAT (U/g Hb) 18124.00 ± 5549.01 15128.00 ± 5067.32 16099.52 ± 5354.30
Resistin (ng/ml) 15.78 ± 2.24 13.95 ± 0.82 5.10 ± 1.20§ǂǂ
TNF-α (pg/ml) 3.44 ± 1.19 2.33 ± 0.81* 1.89 ± 0.9§
Values are means ± SD. d0, beginning of study; d90 and d180, 90 and 180 days after initiating lifestyle advices. SOD, superoxide dismutase; GPx, glutathione
peroxidase; GRed, glutathione reductase; CAT, catalase. TNF-α, tumor necrosis factor α. Data were analyzed using ‘t’ test. *P < 0.05, **P < 0.01, ***P < 0.001: d90
vs d0. §§§P < 0.001, §P < 0.05 d180 vs d0. ǂP < 0.05, ǂǂP < 0.01: d180 vs d90.
Table 4 Correlation studies between HbA1c, HOMA-IR
and resistin and various parameters in T2D patients
HbA1c HOMA-IR Resistin
T2D duration 0.050 −0.130 −0.010
IMC 0.410** 0.230 0.050
WC 0.050 0.850 0.078
Glucose 0.420*** 0.010 −0.100
TG 0.190 −0.180 −0.190
TC 0.100 0.130 0.410***
TBARS 0.300* −0.007 0.370
Hydroperoxydes 0.130 0.270* 0.004
NO 0.055 0.270* 0.400**
carbonyls 0.130 −0.030 0.083
Uric acid 0.100 −0.290* −0.250*
Albumin −0.210 −0.051 −0.060
SOD 0.085 −0.600 −0.320*
CAT 0.263* 0.070 0.017
GPx −0.160 −0.050 −0.010
GRed 0.330** 0.100 −0.040
TNF-α 0.180 0.012 0.400***
Resistin 0.005 0.350**
The values expressed as Pearson’s correlation coefficients.
*Correlation is significant at P < 0.05. **Correlation is significant at P < 0.01.
***Correlation is significant at P < 0.001.
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pared with d0. However, GRed activity was reduced by
42% at d90 vs d0.
Resistin values were 3- and 2.7-fold lower, in T2D at
d180 than d0 and d90 respectively. Moreover, TNF-α
concentrations were 1.5- and 1.8-fold decreased at d90
and d180, after nutritional advices than d0.
Relationships were found between HbA1c values and
BMI, TBARS, CAT and GRed. HOMA-IR was correlated
negatively with UA and positively with NO and resistin.
However, inverse relationships were noted between
resistin and UA and SOD, and positive correlations were
observed with TG, NO and TNF-α (Table 4).
Discussion
The aim of the present study was to determine if the nu-
tritional advices improved glycemic control, redox and
inflammatory status in T2D patients treated with OAD
only.
After nutritional advices based on eating FFV and car-
bohydrates distribution at each meal, T2D patients showed
no significant difference in BMI and WC, whereas, large
studies showed that excessive abdominal fat deposition is
an important risk factor for T2D [21] and that high WC is
a better predictor than BMI [22].
Lowering HbA1c in T2D decreased the CVD risk and
all mortality causes [23]. After d90 and d180 of nutritional
advices, HbA1c and glucose values lowered significantly
in T2D, showing relationships between glycemic control
and BMI. This improvement was probably due to the
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activity practice. Indeed, a moderate effect of regular phys-
ical exercise with a mean HbA1c decrease, without signifi-
cant weight loss, was observed despite favorable changes
in body weight composition [24]. Similar results showed,
that three months consumption of fruits, reduced blood
glucose and HbA1c levels, whereas, no significant changes
were noted in BMI and WC [25]. At d180 vs d90, in-
creased serum glucose level was noted, without change in
serum insulin concentrations, whereas HOMA-IR had a
tendency to decrease but not significantly. The most
plausible explanation, for this phenomenon, was that d180
corresponded to summer period with many festive meals,
and during holidays, people were customarily physically
inactive and were prone to forget diet recommendations.
Indeed, it has been shown that seasons can influence fast-
ing glucose and HbA1c in T2D patients [26]. Our T2D
patients were instructed to consume 2 table spoons of
olive oil daily and fish intake 2-times weekly. Indeed, data
have shown that n-3 poly-unsaturated fatty acids (PUFAs)
from fish may decrease IR through several mechanisms,
such as a decrease in plasma TG, and perhaps small dense
lipoproteins [27], and the consumption of mono-unsatur-
ated FA (MUFA)-rich diet improve IR in T2D [28].
A high intake of dry or fresh vegetables and fruits was
associated with a better control regulation of lipid profile
[29]. In the present study, nutritional advices reduced
serum TC and TG at d90 vs d0. Indeed, dietary MUFA
(oleic acid) decreased LDL-C and TG concentrations,
without lowering high-density lipoproteins-cholesterol
(HDL-C) [30]. Moreover, the improved lipid profile was
probably due to the daily regular 30 to 45 min walking
by our patients. Indeed, physical activity decreased TG
and LDL particles and enhanced HDL-C [31].
T2D is associated with increased oxidative stress, con-
tributing to this pathogenesis [32], by increasing serum
TBARS [33] and hydroperoxides [34]. At d180 and d90
compared to d0, TBARS and hydroperoxides concentra-
tions were significantly reduced in our T2D patients.
Furthermore, the lowered lipid peroxidation could be
due to the improved glycemic control, and therefore to a
lesser oxidative stress, showing relationships between
TBARS and HbA1c. Likewise, consumption of fruits and
vegetables, rich in antioxidants, could play an important
role in protecting our patients from oxidative stress gen-
erated by T2D.
A high level of plasma protein carbonyls has been re-
ported in T2D patients [35], and can also originate from
a loss of albumin antioxidant capacity, knowing that
plasma albumin, via its thiol groups, is the main extra-
cellular antioxidant molecule [36]. In our study, serum
carbonyl values had a tendency to decrease, whereas
serum albumin value was enhanced, after lifestyle ad-
vices, suggesting that improved glycemic control canreduce oxidative stress, and therefore carbonyl amounts,
without altering albumin properties.
Some controversies about the NO role are noted in the
IR pathogenesis [37]. Moreover, NO, a metabolite of L-
arginine to L-citrulline conversion by endothelial NO
synthase, has a favorable effect on inflammation [38], and
oxidative stress [39]. A decrease in NO values at d180 vs
d0 and d90 was noted and was positively correlated with
IR and serum resistin.
Hyperuricaemia is associated with IR [40], which is me-
diated partly by inflammation and oxidative stress [41].
However, our results showed, at d180 vs d0, that high UA
level was inversely related to HOMA-IR and resistin. In-
deed, this result suggested that uric acid value was effi-
cient to reduce IR and inflammation in T2D.
Besides the important lipid peroxidation in T2D pa-
tients, an increase in SOD activity was observed in such
individuals [42]. In our T2D patients, erythrocytes SOD
activity increased at d180 vs d0 (P < 0.05), suggesting a
possible adaptative response, probably due to a high pro-
duction of superoxide anion (O2
−), which would lead to
an increased hydrogen peroxide (H2O2) production [42].
This latter has been reported to inactivate SOD, and
superoxide anion radical inactivates CAT [43], and GPx
[44]. However, there was no significant difference in the
both enzyme activities at d180 vs d0. In our T2D pa-
tients, GRed activity was lower, while GPx was higher, at
d90 vs d0. In contrast, diabetic complications involved
lowered GPx activity, which could also be due to de-
creased glucose-6-phosphate dehydrogenase activity, in
erythrocytes [45], leading to reduced NADPH produc-
tion, required for recycling processes of GSSG to GSH,
which was the GPx substrate [45].
There is a genetic evidence to support relationships
between human inflammation, in particular resistin and
obesity or IR [46]. In the present study, lowered serum
resistin values, at d180 vs d90 and d0, were observed,
and were positively correlated with IR. Moreover, TNF-α
was reduced significantly in T2D, after nutritional ad-
vices, compared to the beginning of the study. High
levels of inflammatory cytokines appear in early stage of
T2D, and predict the development of this disease,
through lowering insulin sensitivity [47]. Indeed, a highly
significant relationship between resistin and TNF-α, and
a negative correlation between resistin and SOD were
observed. Moreover, observational studies have shown
an inverse association between dietary total antioxidant
capacity and inflammation markers [48], whereas, n-3
PUFA supplementation may potentially affect these
markers, in patients with T2D [49]. In our study, rec-
ommended FFV could contribute probably to decreased
serum resistin and TNF- α, and thus protecting the
organism from proinflammatory cytokines deleterious
effects.
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The nutritional advices follow-up i.e. FFV consumption,
and carbohydrates distribution at each meal, associated
to a regular physical activity practice, improve glycemic
control and serum total cholesterol in T2D. Moreover, a
low lipid peroxidation and a high antioxidant defense
are noted, involving a less oxidative stress induced by
T2D, on the one hand, and reduced serum resistin and
TNF-α are in favor of a low progression to complica-
tions, on the other hand. However, these results need to
be supported with a regular dietary treatment and more
rigorous control during the follow-up.
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